Helicobacter pylori infection
Conditions
Interventions
The experimental group:Huoxiang anwei Capsule
Sponsors
Spleen and Stomach Department, Shenzhen Hospital of Traditional Chinese Medicine, No. 1 fuhua Road, Futian District, Shenzhen city
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (1) Meet the diagnostic criteria for Hp infection; (2) 18-65 years old; (3) Voluntarily accept the experiment and sign the informed consent.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1) Patients with serious lesions of heart, liver and kidney, hematopoietic system diseases and tumors; (2) Antibiotics, acid suppressants and bismuth were used within 4 weeks before treatment; (3) Systemic diseases that affect the motility of the digestive tract (e.g., hyperthyroidism, diabetes, chronic renal insufficiency, mental and neurological disorders) Pathological changes, etc.); (4) those with a history of abdominal surgery (except appendectomy and cesarean section); (5) pregnant or planning to be pregnant, breast-feeding women; (6) Those who have a history of drug allergy or severe food allergy used in the study; Project Name: Huoxiang Anwei Capsule in the treatment of Helicobacter pylori infection randomized controlled clinical study Version no. : Version 1.0 Date: 20220330 3/5 (7) have a history of neurological and mental diseases; (8) Subjects who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori results; | — |
Countries
China
Contacts
Public ContactXu Yifei
Outcome results
None listed